Stuart Weiss, M.D.

Medical Alumnus Encourages Others to Give Back

Although it has been nearly 50 years since Stuart R. Weiss, M.D. ’71, graduated from the University of Miami School of Medicine, he is still dedicated to ensuring the future of his medical alma mater. Weiss, an endocrinologist, has been a generous supporter of the medical school for more than 40 years. His first gift to the school came just three years after graduation.

Read more about Dr. Weiss's generosity »

Amiethab A. Aiyer, M.D., demonstrates proper ankle wrapping to a group of medical students.

Dr. Amiethab A. Aiyer Receives Grant to Study Prevention of Arthritis in the Ankle

In hopes of finding new ways to potentially prevent the debilitating effects of arthritis in different regions of the ankle, Amiethab A. Aiyer, M.D., chief of the Foot & Ankle Service and assistant professor in the University of Miami Miller School of Medicine’s Division of Orthopaedic Surgery, recently received a prestigious research grant from the American Orthopaedic Foot & Ankle Society (AOFAS).

Read more about Dr. Aiyer's grant »

Project: New Born donors Jorge and Mairi Bustamante, with their son, Jaxon, and Eduardo Bancalari, M.D. Mairi shows off a bottle of Little Wings wine commemorating daughter, Mikaela, who was cared for at the Schatzi and Stanley Kassal Project: New Born Neonatal Intensive Care Unit (NICU) at Holtz Children’s Hospital at the UM/Jackson Memorial Medical Center.

Little Wings Wine Label Lifts Miller School’s Division of Neonatology

They say that whenever an angel gets its wings, a bell rings. The bell that Miami resident Jorge Bustamante heard in his head three years ago may well have been a sign that his beloved daughter, Mikaela, whose life ended far too soon, had gotten her wings. But it also signaled the genesis of an idea Jorge had that would turn anguish into action, and tragedy into tribute.

Read more about Little Wings wine »

Team members of the Sylvester Phase 1 clinical trials program.

Sylvester Provides 100 Patients Potentially Life-Saving Treatments in its Phase 1 Trial Program

Dr. Jaime Merchan is thrilled that Sylvester Comprehensive Cancer Center has reached the milestone number of 100 patients enrolled in a single year in its Phase 1 clinical trials program. The program, which tests new drugs and other novel treatment strategies for advanced solid tumors and hematological malignances, offers these patients something they couldn’t find elsewhere: hope.

Read more about the Phase 1 program »

Sylvester Comprehensive Cancer Center.

New Analysis: Patients Receiving Chemo for Cancer at ADCC Institutions Have Highest Survival Rates

Patients treated with chemotherapy for some of the most common types of cancer at Dedicated Cancer Centers have higher survival rates compared to patients treated at other types of hospitals, according to new analysis conducted by Milliman for the Alliance of Dedicated Cancer Centers. Sylvester Comprehensive Cancer Center is one of only 11 members of the Alliance of Dedicated Cancer Centers.

Read more about Sylvester's chemotherapy patient survival rates »

News Archives

Office of the Dean

A message from the dean

Physician News

Read Med News


Read e-Update